Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 [Imaging diagnostics of advanced prostate cancer].

Literature DB >> 23483268

[Imaging diagnostics of advanced prostate cancer].

A Kretschmer¹, M Seitz, A Graser, C G Stief, D Tilki.

Abstract

The diagnostic approach to prostate cancer is still a big challenge for the treating physician. Regarding an individualized and risk-adapted evaluation of different therapeutic options, precise diagnostic tools are crucial to accurately distinguish between localized and advanced prostate cancer. Imaging of advanced prostate cancer is currently changing due to numerous technical innovations. While choline-based hybrid positron emission tomography-computed tomography (PET/CT) has been established as an important diagnostic tool in clinical imaging of advanced prostate cancer, well-investigated methods, such as magnetic resonance imaging (MRI) and bone scintigraphy are currently expanding the diagnostic potential due to technical improvements. The specific use of imaging for advanced prostate cancer may help to offer the patient a well-tailored oncologic therapy. Further research is needed to evaluate whether this individualized therapy can consistently improve the prognosis of patients suffering from advanced prostate cancer.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2013 PMID： 23483268 DOI： 10.1007/s00120-012-3095-z

Source DB: PubMed Journal: Urologe A ISSN： 0340-2592 Impact factor: 0.639

61 in total

1. Pretreatment staging of clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria.

Authors: E S Amis; L R Bigongiari; E I Bluth; W H Bush; P L Choyke; P Fritzsche; L Holder; J H Newhouse; C M Sandler; A J Segal; M I Resnick; E A Rutsky
Journal: Radiology Date: 2000-06 Impact factor: 11.105

2. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.

Authors: Igle J de Jong; Jan Pruim; Philip H Elsinga; Willem Vaalburg; Han J Mensink
Journal: J Nucl Med Date: 2003-03 Impact factor: 10.057

Review 3. Dietary choline: biochemistry, physiology, and pharmacology.

Authors: S H Zeisel
Journal: Annu Rev Nutr Date: 1981 Impact factor: 11.848

4. Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy.

Authors: C Hofer; C Laubenbacher; T Block; J Breul; R Hartung; M Schwaiger
Journal: Eur Urol Date: 1999 Impact factor: 20.096

5. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.

Authors: Tom Budiharto; Steven Joniau; Evelyne Lerut; Laura Van den Bergh; Felix Mottaghy; Christophe M Deroose; Raymond Oyen; Filip Ameye; Kris Bogaerts; Karin Haustermans; Hendrik Van Poppel
Journal: Eur Urol Date: 2011-01-18 Impact factor: 20.096

6. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.

Authors: Axel Häcker; Stefan Jeschke; Karl Leeb; Kurt Prammer; Josef Ziegerhofer; Wolfgang Sega; Werner Langsteger; Guenter Janetschek
Journal: J Urol Date: 2006-11 Impact factor: 7.450

7. Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer.

Authors: Ludwig Rinnab; Felix M Mottaghy; Norbert M Blumstein; Sven N Reske; Richard E Hautmann; Kathrin Hohl; Peter Möller; Thomas Wiegel; Rainer Kuefer; Juergen E Gschwend
Journal: BJU Int Date: 2007-10 Impact factor: 5.588

[Imaging diagnostics of advanced prostate cancer].

1. Pretreatment staging of clinically localized prostate cancer. American College of Radiology. ACR Appropriateness Criteria.

2. Preoperative staging of pelvic lymph nodes in prostate cancer by 11C-choline PET.

Review 3. Dietary choline: biochemistry, physiology, and pharmacology.

4. Fluorine-18-fluorodeoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy.

5. Prospective evaluation of 11C-choline positron emission tomography/computed tomography and diffusion-weighted magnetic resonance imaging for the nodal staging of prostate cancer with a high risk of lymph node metastases.

6. Detection of pelvic lymph node metastases in patients with clinically localized prostate cancer: comparison of [18F]fluorocholine positron emission tomography-computerized tomography and laparoscopic radioisotope guided sentinel lymph node dissection.

7. Evaluation of [11C]-choline positron-emission/computed tomography in patients with increasing prostate-specific antigen levels after primary treatment for prostate cancer.

8. The flare phenomenon on radionuclide bone scan in metastatic prostate cancer.

Review 9. Non-invasive molecular imaging of prostate cancer lymph node metastasis.

Review 10. Imaging metastatic bone disease from carcinoma of the prostate.

1. [Sub-threshold prostate-specific antigen levels after resection of metachronous pulmonary metastases].